Browsing Tag
Ifezuntirgene Inilparvovec
2 posts
uniQure shares tumble as Huntington’s gene therapy shows weaker four-year cUHDRS benefit
uniQure shares plunge as four-year ifezuntirgene data show mixed Huntington’s results while the gene therapy awaits FDA review.
October 1, 2026
uniQure files AMT-130 in U.S. and U.K. as Huntington’s gene therapy reaches regulators
uniQure has submitted AMT-130 for accelerated U.S. approval and filed simultaneously in the United Kingdom, moving the Huntington’s gene therapy from regulatory planning into formal review.
September 7, 2026